Faheem W Guirgis, MD, FACEP

Faheem W. Guirgis, M.D., is an endowed professor of emergency medicine at the University of Florida. His research program’s goal is to define the pathophysiologic role of lipids and lipoproteins in mediating organ failure, inflammation, and recovery from sepsis and to discover precision medicine treatments. He designed a Phase I and Phase II clinical trial testing the safety and efficacy of a lipid emulsion for stabilizing cholesterol levels in septic shock. He has been the recipient of multiple NIH awards to fund his research. Dr. Guirgis has also been a proponent and leader of research education and is MPI and Co-director of the UF-FSU NCATS KL2 Program.

Sepsis, Critical Care, Resuscitation

Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.